About Koninklijke Philips N.V. NY Registry Shares (PHG)
Koninklijke Philips Electronics is a global leader in health technology, focused on improving people's lives through meaningful innovation. The company develops a wide range of products and solutions, including medical devices, diagnostic imaging, patient monitoring systems, and consumer health products. Its commitment to enhancing healthcare and well-being extends into areas such as personal health, connected care, and sustainable development, aiming to deliver integrated solutions that empower both health professionals and patients. Philips combines advanced technologies with deep clinical and consumer insights to create solutions that drive better outcomes and improve the quality of care across various settings. Read More
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, “Building trust in healthcare AI,” spotlighting the state of healthcare and uncovering a significant trust gap between healthcare professionals (HCPs) and patients around the role of AI in healthcare. This 10th edition report, commissioned by Philips, reveals a healthcare system under mounting strain and signals that AI can help. However, gaps in trust in AI threaten to stall progress.
May 15, 2025AI has the power to cut care delays and manage data overload, but trust gaps among clinicians and patients threaten to slow adoption and impactAmsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has released its 10th annual Future Health Index (FHI) report, highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery. However, gaps in trust threaten to stall progress at a time when innovation is most needed.“The need to transform healthcare delivery has never been more urgent,” said Carla Goulart Peron, M.D., Chief Medical Officer at Philips. “In more than half of the 16 countries surveyed, patients are waiting nearly two months or more for specialist appointments, with waits in Canada and Spain extending to four months or longer. As healthcare systems face mounting pressures, AI is rapidly emerging as a powerful ally, offering unprecedented opportunities to transform care and overcome today’s toughest challenges.”Long waits, worsening outcomesThe FHI 2025 report reveals 33% of patients have experienced worsening health due to delays in seeing a doctor, and more than 1 in 4 end up in the hospital due to long wait times. “Cardiac patients face especially dangerous delays, with 31% being hospitalized before even seeing a specialist. Without urgent action, a projected shortfall of 11 million health workers by 2030 could leave millions without timely care,” Dr. Peron added.Clinician burnout and data burdens call for digital reliefMore than 75% of healthcare professionals report losing clinical time due to incomplete or inaccessible patient data, with one-third losing over 45 minutes per shift, adding up to 23 full days a year lost by each professional. “These inefficiencies amplify stress on already understaffed teams and contribute to burnout,” said Gretchen Brown, RN, VP and Chief Nursing Information Officer at Stanford Health Care. “Recognizing this, as clinicians, we see AI as a solution and understand that delayed adoption can also carry major risks.” Of the nearly 2,000 healthcare professionals surveyed, if AI is not implemented:
Philips topped Q1 profit estimates with €0.25 EPS, cut its 2025 margin outlook due to tariffs, and reported €1.09 billion cash outflow tied to U.S. settlements.
Ukraine is recognized as a country with significant mineral wealth, including a variety of rare earth elements (REEs) and other critical minerals. These resources have drawn global attention, particularly amid the ongoing war with Russia, rising geopolitical tensions, and the push for secure supply chains outside of China, which dominates
Koninklijke Philips NV (PHG) is a diversified global healthcare company. Philip’s price grew about 32% in the past year from $19.34 to $25.48 as of Tuesday’s market close.
March 24, 2025Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2025 and published the agenda with explanatory notes.As previously announced, the agenda includes:
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Ingeborg Initiatives are teaming up to provide all expectant parents in Arkansas with access to Philips Avent Pregnancy+ app with customized state-offered information and tools to increase access to care, improve health literacy and adopt healthy habits. State residents who download the Pregnancy+ app will automatically receive access to this premium, customized content.
March 12, 2025Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has been recognized by Clarivate as the top-ranked medical technology company in the Top 100 Global Innovators 2025, reinforcing its global reputation as a leading healthcare innovator. A consistent high-performer, Philips has been included in this major assessment of global innovators for 12 consecutive years. Roy Jakobs, CEO of Royal Philips said: "At Philips, we’ve been innovating for over 130 years to improve people’s lives. Innovation is our fundamental strength, the reason why customers choose us as their strategic partner and a key value driver for our company. Our portfolio of patient- and people-centric innovations in hardware, software, AI and services drives healthcare productivity and empowers people to look after their health and well-being – delivering better care for more people."In 2024, Philips invested approximately EUR 1.7 billion – or an industry leading >9% of sales – in research and development to help drive better care for more people. Philips is increasingly focusing its innovation efforts on the potential of data and AI, both in hospital settings and at home. As a leader in AI-related patent applications in healthcare, Philips dedicates around half of its R&D workforce to these fields. Examples of Philips’ AI-powered innovations that increase caregiver productivity and deliver better care for more people include:
Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced that Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has selected AWS as its preferred cloud provider to advance its business transformation and deliver secure and innovative healthcare informatics solutions globally. Philips’ cloud-first, AI-enabled approach is improving the company’s ability to deliver better care for more people, providing faster product development and reduced infrastructure costs.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, Amerigroup, CareSource Georgia, and Peach State Health Plan have partnered to provide remote monitoring solutions to expand access to quality healthcare for high-risk pregnancies in the state. In support of the Georgia Healthy Babies Act, the program will initially give pregnant and postpartum people with maternal hypertension and diabetes in 50 counties access to remote patient monitoring. Licensed clinical professionals will provide personalized health coaching to participants, monitoring them and intervening to avoid possible complications.
Philips Q4 earnings missed estimates as sales hit €5.04 billion. The company raised its 2023-2025 savings target to €2.5 billion and expects 2025 sales growth of 1%-3%.
